Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institution.

Brachytherapy

Alfred Health Radiation Oncology Service, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Published: June 2017

Purpose: To evaluate the incidence of acute urinary toxicity after permanent seed prostate brachytherapy (BT) over a 15-year period.

Methods And Materials: The study consisted of 782 prostate cancer patients treated with BT. All patients completed self-administered International Prostate Symptoms Score (IPSS) at baseline and during regular follow-up. We evaluated the risk of acute urinary retention (AUR) up to 3 months post-BT and lower urinary tract symptom (LUTS) resolution (defined as return to within two points of baseline IPSS score) at regular intervals, up to 24 months post-BT. Univariate and multivariate logistic regressions were used to evaluate the effect of various patient, tumor, and treatment factors on the risk of AUR and the likelihood of LUTS resolution.

Results: Ninety-six patients (12%) developed AUR at a median of 1 day post-BT. Increased peak urinary flow is independently associated with lower risk of AUR (odds ratio [OR] = 0.94; 95% confidence interval [CI] = 0.91-0.97). Decline in incidence of AUR was observed over time with increased institutional experience (p = 0.03). Of the 646 patients with a minimum of 24-month follow-up, 29%, 49%, and 72% had LUTS resolution at 6, 12, and 24 months, respectively. Patients who had pre-BT transurethral resection of prostate (OR = 2.4; 95% CI = 1.5-4.0), cytoreductive neo-adjuvant androgen deprivation (OR = 2.0; 95% CI = 1.0-4.0), and higher baseline IPSS (OR = 1.1; 95% CI = 1.07-1.19) are more likely to report LUTS resolution at 24 months.

Conclusions: We reported decline in AUR over time with increased institutional experience in one of the largest Australasian BT series. Approximately three-quarters of patients achieved LUTS resolution at 24-month follow-up.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2016.11.010DOI Listing

Publication Analysis

Top Keywords

luts resolution
16
acute urinary
12
increased institutional
12
institutional experience
12
or = 95%
12
95% ci =
12
permanent seed
8
seed prostate
8
prostate brachytherapy
8
months post-bt
8

Similar Publications

Objectives: During holmium laser enucleation of the prostate (HOLEP), blunt dissection (BD) by pushing the tip of the scope may exert mechanical force on the sphincter that could be avoided by adopting laser dissection (LD). This study evaluates the continence recovery in consecutive patients who underwent BD and LD.

Methods: A prospective cohort of patients who underwent LD was compared with a retrospective control that underwent BD.

View Article and Find Full Text PDF

Advancements in digital imaging and video processing are often challenged by low-light environments, leading to degraded visual quality. This affects critical sectors such as medical imaging, aerospace, and underwater exploration, where uneven lighting can compromise safety and clarity. To enhance image quality in low-light conditions using a computationally efficient system.

View Article and Find Full Text PDF

Background: Advanced prostate cancer leads to many symptoms, notably bone pain and lower urinary tract symptoms (LUTs); however, the degree and duration of pain relief, changes in LUTs severity and underlying factors associated with the extent of symptom relief remain inadequately understood. Surgical castration has proven effective in relieving both bone pain and urinary symptoms for metastatic prostate cancer patients.

Objective: To determine the extent and pattern of symptom relief in advanced prostate cancer patients following surgical castration at Muhimbili National Hospital (MNH).

View Article and Find Full Text PDF
Article Synopsis
  • A case study was conducted on a 67-year-old man experiencing lower urinary tract symptoms (LUTS) who underwent a novel surgical procedure called transperineostomal bipolar resection of the prostate (TPR-P), which had not been previously reported in medical literature.
  • The patient, with a complex medical history including Fournier's gangrene and bulbar stenosis, faced complications with catheterization but showed significant improvement following the TPR-P surgery, with reduced urinary symptoms and post-voiding residual volume.
  • Despite concerns about the suitability of traditional resection techniques due to the patient's unique anatomy, TPR-P proved to be effective and safe, leading to notable enhancements in urinary function and patient satisfaction post-operation.
View Article and Find Full Text PDF

Introduction: During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the management of patients with lower urinary tract symptoms (LUTS) underwent dynamic adjustments in response to an evolving understanding of the virus's impact on different patient populations. Healthcare practitioners reevaluated therapeutic approaches for conditions like benign prostatic hyperplasia (BPH), considering the potential implications of this condition on the severity and progression of coronavirus disease 2019 (COVID-19). This study aims to investigate potential correlations between SARS-CoV-2 infection severity, exacerbation of LUTS, and BPH progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!